Table 2. Comparison of VIA and large lesion results in new women screened, by country and HIV status, January 2009 –March 2012.
| Screening Result, by Country | Total N = 34,921 | HIV Positive N = 9,181 | HIV negative/ unknown N = 25,740 | P-value |
|---|---|---|---|---|
| Côte d’Ivoire | n = 7,538 | n = 5,782 | n = 1,756 | |
| VIA negative | 6,969 (92%) | 5,268 (91%) | 1,701 (97%) | < 0.0001 |
| VIA positive | 519 (7%) | 473 (8%) | 46 (3%) | < 0.0001 |
| Large lesions | 159 (31%) | 152 (32%) | 7 (15%) | 0.0175 |
| Cryotherapy eligible | 360 (69%) | 321 (68%) | 39 (84%) | 0.0175 |
| Suspect cancer | 50 (.7%) | 41 (0.7%) | 9 (0.5%) | 0.3741 |
| Guyana | n = 19,934 | n = 1,602 | n = 18,332 | |
| VIA negative | 17,297 (87%) | 1,344 (84%) | 15,953 (87%) | < 0.0001 |
| VIA positive | 2,529 (13%) | 256 (16%) | 2,273 (12%) | < 0.0001 |
| Large lesions | 381 (15%) | 62 (24%) | 319 (14%) | < 0.0001 |
| Cryotherapy eligible | 2,148 (85%) | 194 (76%) | 1,954 (86%) | < 0.0001 |
| Suspect cancer | 108 (.5%) | 2 (0.1%) | 106 (0.6%) | 0.0178 |
| Tanzania | n = 7,449 | n = 1,797 | n = 5,652 | |
| VIA negative | 6,739 (90%) | 1,531 (85%) | 5,208 (92%) | < 0.0001 |
| VIA positive | 532 (7%) | 237 (13%) | 295 (5%) | < 0.0001 |
| Large lesions | 82 (15%) | 51 (22%) | 31 (11%) | 0.0005 |
| Cryotherapy eligible | 450 (85%) | 186 (78%) | 264 (89%) | 0.0005 |
| Suspect cancer | 178 (2%) | 29 (1.6%) | 149 (2.6%) | 0.0134 |